QIV | TIV-Vic | TIV-Yam | |
---|---|---|---|
N = 3036 | N = 1010 | N = 610 | |
Adverse events Day 0–20, n (%) | |||
Subjects with ≥ 1 event | 379 (12.5) | 138 (13.7) | 92 (15.1) |
Subjects with ≥ 1 Grade 3 event | 39 (1.3) | 7 (0.7) | 2 (0.3) |
Subjects with ≥ 1 event related to vaccination† | 64 (2.1) | 26 (2.6) | 14 (2.3) |
No. of events by MedDRA preferred term | 558 | 195 | 125 |
No. of Grade 3 events by MedDRA preferred term | 52 | 8 | 2 |
No. of events by MedDRA preferred term related to vaccination† | 89 | 38 | 16 |
Medically-attended adverse events Day 0–20, n (%) | |||
Subjects with ≥ 1 event | 193 (6.4) | 60 (5.9) | 47 (7.7) |
No. of events by MedDRA preferred term | 250 | 75 | 63 |
Medically-attended adverse events Day 0–180, n (%) | |||
Subjects with ≥ 1 event | 688 (22.7) | 216 (21.4) | NA* |
No. of events by MedDRA preferred term | 1151 | 379 | NA* |